Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53)

Journal of Clinical Oncology

Volumn 25, Issue 21, 2007, Pages 3124-3129

  Schild, Steven E ^a   Bonner, James A ^a   Hillman, Shauna ^a   Kozelsky, Timothy F ^a   Vigliotti, Antonio P G ^a   Marks, Randolph S ^a   Graham, David L ^a   Soori, Gamini S ^a   Kugler, John W ^a   Tenglin, Richard C ^a   Wender, Donald B ^a   Adjei, Alex ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; AGED; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER CONTROL; CANCER RADIOTHERAPY; CARDIOTOXICITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG TOLERABILITY; ESOPHAGITIS; FEMALE; HUMAN; INFECTION; LETHARGY; LUNG SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SKULL IRRADIATION; SURVIVAL RATE; TREATMENT FAILURE; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ETOPOSIDE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, HIGH-ENERGY; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34547666595     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.9606     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56:106-130, 2006
2. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890-895, 1992
3. National Cancer Institute: Small cell lung cancer (PDQ): treatment. http://www.cancer.gov/cancertopics/pdq/treatment/small-celHung/ healthprofessional
4. Green RA, Humphrey E, Close H, et al: Alkylating agents in bronchogenic carcinoma. Am J Med 46:516-525, 1969
5. Pignon JP, Arriagada R, Ihde DC, et al: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1618-1624, 1992
6. G. Aupérin A, Arriagada R, Pignon JP, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission: Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341:476-484, 1999
7. Turrisi AT III, Kim K, Blum R, et al: Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265-271, 1999
8. Komaki R, Swann RS, Ettinger DS, et al: Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12. Int J Radiat Oncol Biol Phys 62:342-350, 2005
9. Bogart JA, Herndon JE II, Lyss AP, et al: 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: Analysis of Cancer and Leukemia Group B study 39808. Int J Radiat Oncol Biol Phys 59:460-468, 2004
10. Bonner JA, Hillman S, Vigliotti A, et al: High dose, twice-daily thoracic radiotherapy (TRT) with daily chemotherapy in limited stage small cell lung cancer. Presented at the Annual Meeting of the International Association for the Study of Lung Cancer, Lung Cancer 42:23, 2003 (abstr 0-73)
11. Schild SE, Bonner JA, Shanahan TG, et al: Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 59:943-951, 2004
12. Shaw EG, McGinnis WL, Jett JR, et al: Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung. J Natl Cancer Inst 85:321-323, 1993
13. De Ruysscher D, Pijls-Johannesma M, Bentzen SM, et al: Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 24:1057-1063, 2006
14. Fried DB, Morris DE, Poole C, et al: Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 22:4837-4845, 2004
15. Hall EJ: Radiology for the Radiologist (ed 5). Philadelphia, PA, Lippincott Williams and Wilkins, 2000
16. Fowler JF: Biological factors influencing optimum fractionation in radiation therapy. Acta Oncol 40:712-717, 2001
17. Fowler JF: The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679-694, 1989
18. Tinnemans MM, Schutte B, Lenders MH, et al: Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling. Br J Cancer 67:1217-1222, 1993
19. Shibamoto Y, Ike O, Mizuno H, et al: Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome. Clin Cancer Res 4:677-682, 1998
20. Kerr KM, Lamb D: Actual growth rate and tumour cell proliferation in human pulmonary neoplasms. Br J Cancer 50:343-349, 1984
21. Qiao TK, Zhou DA, Xin L, et al: Concurrent radiotherapy combined with carboplatin and etoposide in limited stage small cell lung cancer. Zhonghua Jie He He Hu XiZa Zhi 27237-239, 2004
22. Jeremic B, Shibamoto Y, Acimovic L, et al: Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: A randomized study. J Clin Oncol 15:893-900, 1997
23. Takada M, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20:3054-3060, 2002